Healthcare
Latest Healthcare News
View MoreLatest Healthcare Analysis
View More
IPO Outlook: LSDI, QSG
The IPOs in focus for the week ahead include psychotropic ingredient outfit Lucy Scientific Discovery and online education specialists QuantaSing...

Earnings Preview: CMC, SNX, KBH, DAL, UNH
This week’s company earnings include Commercial Metals Company (NYSE: CMC), TD Synnex Corp (NYSE: SNX), KB Home (NYSE: KBH), Delta Air Lines, Inc....

Earnings Preview: SGH, SLP, STZ, GBX
This week’s company earnings include SMART Global Holdings (NASDAQ: SGH), Simulations Plus (NASDAQ: SLP), Constellation Brands Inc (NYSE: STZ) and...

IPO Outlook: ATMVU, BFRG
The IPOs to look out for this week include Asia-focused SPAC AlphaVest Acquisition and medicine development and AI specialist BullFrog AI.
Top Picks
View More
Top Growth Stocks Q2 2022
Growth investing tends to be a medium to long-term investing strategy. Investors looking for growth stocks seek companies that appear to have a...

Top Growth Stocks Q1 2022
Growth investing tends to be a medium to long term investing strategy. Investors looking for growth stocks seek companies that appear to have a...

Top Momentum Stocks Q1 2022
Momentum investing tends to be a short-term investing strategy. Investors looking to buy shares in a stock look for signs of upward momentum and...

Q4 2021 Top Healthcare stocks to consider
Healthcare can be a lucrative investment area, but it's also a challenging sector to invest in. Here are some top health stocks in momentum, growth...
Press Releases
View More
Cardiol Therapeutics Announces Pre-Clinical Study Results Demonstrating CardiolRx™ Inhibits and also Promotes Reversal of Mechanisms Leading to Cardiac Fibrosis
Announcing study results demonstrate the active pharmaceutical ingredient (“API”) in CardiolRx™ inhibits and also promotes the reversal of...

Cardiol Therapeutics Appoints Two New Directors To Its Board
Oakville, Ontario--(Newsfile Corp. - May 19, 2022) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a...

Cardiol Therapeutics Announces FDA Investigational New Drug Application
Third IND authorization for CardiolRx™ in cardiovascular disease means this latest study will run in parallel with Company's multi-national Phase...